In conclusion, this study shows that Trx system proteins, namely TrxR, Trx and TxNIP, are widely expressed across a variety of brain tumour types with high cytoplasmic TrxR expression consistently associating with worse prognosis in all brain tumour types, suggesting that TrxR is a potentially important therapeutic target in brain cancers. This evidence concerns the gene TXN and brain neoplasm.